Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy.
Jackson WC, Johnson SB, Li D, Foster C, Foster B, Song Y, Schipper M, Shilkrut M, Sandler HM, Morgan TM, Palapattu GS, Hamstra DA, Feng FY. Jackson WC, et al. Among authors: johnson sb. Radiat Oncol. 2013 Jul 8;8:170. doi: 10.1186/1748-717X-8-170. Radiat Oncol. 2013. PMID: 23835115 Free PMC article.
Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer.
Hamstra DA, Stenmark MH, Ritter T, Litzenberg D, Jackson W, Johnson S, Albrecht-Unger L, Donaghy A, Phelps L, Blas K, Halverson S, Marsh R, Olson K, Feng FY. Hamstra DA, et al. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1246-53. doi: 10.1016/j.ijrobp.2012.10.042. Epub 2012 Dec 19. Int J Radiat Oncol Biol Phys. 2013. PMID: 23265567
Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Johnson SB, Hamstra DA, Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY. Johnson SB, et al. Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):275-81. doi: 10.1016/j.ijrobp.2013.05.043. Epub 2013 Jul 23. Int J Radiat Oncol Biol Phys. 2013. PMID: 23886418
Time to Nadir PSA: Of Popes and PSA--The Immortality Bias.
Johnson SB, Jackson WC, Murgic J, Feng FY, Hamstra DA. Johnson SB, et al. Am J Clin Oncol. 2015 Oct;38(5):465-71. doi: 10.1097/COC.0b013e3182a468b2. Am J Clin Oncol. 2015. PMID: 24064749 Clinical Trial.
Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy.
Jackson WC, Johnson SB, Foster B, Foster C, Li D, Song Y, Vainshtein J, Zhou J, Hamstra DA, Feng FY. Jackson WC, et al. Among authors: johnson sb. Pract Radiat Oncol. 2014 Mar-Apr;4(2):99-107. doi: 10.1016/j.prro.2013.05.008. Epub 2013 Jul 18. Pract Radiat Oncol. 2014. PMID: 24890350
777 results